What You Will Learn in This Article
- Why paracetamol causes liver failure — the exact biochemical mechanism step by step
- The role of NAPQI, glutathione depletion, and cytochrome P450 in hepatotoxicity
- The four clinical stages of paracetamol overdose and what happens in each
- The antidote — N-acetylcysteine — how it works and when to give it
- The Rumack-Matthew nomogram and how it guides treatment decisions
- All other important hepatotoxic drugs and their mechanisms (for comparison MCQs)
- High-yield exam facts, mnemonics, and the most dangerous exam traps on this topic
- 5 original practice MCQs to test yourself immediately
📖 Introduction: Why This Topic Matters in Exams
A 19-year-old student takes “a handful of paracetamol tablets” after a breakup. She feels fine the next day and reassures her family she is okay. By day 3, she is jaundiced, confused, and in acute liver failure. By day 4, without treatment, she may be dead.
This is the classic paracetamol overdose story — and it is terrifying precisely because of the deceptive early symptom-free window that lulls both patients and clinicians into false reassurance. Examiners love this topic because it combines pharmacology (mechanism of toxicity, antidote), biochemistry (CYP450, glutathione, NAPQI), and clinical medicine (staging, prognosis, transplant criteria) into one high-yield package.
Questions appear as: “Most common cause of acute liver failure?”, “Mechanism of paracetamol toxicity?”, “Antidote for paracetamol overdose?”, “Which enzyme metabolises paracetamol to its toxic metabolite?”, “What does N-acetylcysteine do?” — all variants of the same underlying concept. This article gives you complete command of every angle.
🔬 Section 1 — Normal Paracetamol Metabolism
Three Metabolic Pathways
At therapeutic doses, paracetamol (acetaminophen) is metabolised in the liver via three pathways:
| Pathway | Proportion | Product | Fate |
|---|---|---|---|
| Glucuronidation | ~55% | Paracetamol glucuronide | Excreted in urine (non-toxic) |
| Sulphation | ~30% | Paracetamol sulphate | Excreted in urine (non-toxic) |
| CYP450 oxidation | ~5–10% | NAPQI | Detoxified by glutathione → mercapturic acid → excreted |
The key to understanding paracetamol toxicity is understanding this third, minor pathway.
What is NAPQI?
NAPQI stands for N-Acetyl-p-Benzoquinone Imine — the toxic reactive metabolite of paracetamol produced by cytochrome P450 enzymes, primarily CYP2E1 (and to a lesser extent CYP3A4 and CYP1A2).
At therapeutic doses, the tiny amount of NAPQI produced is immediately quenched by glutathione (GSH) in hepatocytes — forming a non-toxic mercapturate conjugate that is safely excreted in urine. No harm done.
🔬 Section 2 — Mechanism of Paracetamol Hepatotoxicity
The Toxic Overdose Cascade
When paracetamol is taken in overdose (typically >7.5–10 g in adults, less in high-risk groups):
Step 1: Glucuronidation and sulphation pathways become saturated — they cannot handle the excess drug load.
Step 2: The overflow is shunted entirely through the CYP2E1 pathway, generating massive amounts of NAPQI.
Step 3: Hepatocyte glutathione stores are rapidly depleted (glutathione is consumed faster than it can be regenerated).
Step 4: Once glutathione falls to <30% of normal levels, NAPQI can no longer be detoxified.
Step 5: Free NAPQI covalently binds to hepatocyte proteins — forming protein adducts that trigger:
- Mitochondrial dysfunction → ATP depletion
- Oxidative stress → lipid peroxidation
- Hepatocyte necrosis → zone 3 (centrilobular) necrosis
Why Zone 3 (Centrilobular)? CYP2E1 is most concentrated in zone 3 (perivenular zone) of the hepatic acinus — the zone furthest from the portal blood supply and already relatively oxygen-poor. This is the zone that generates the most NAPQI and suffers the most damage. Zone 3 necrosis is the histological hallmark of paracetamol hepatotoxicity.
Factors That Increase Toxicity (Increase CYP2E1 Activity or Reduce Glutathione)
These are heavily tested because they explain why “safe” doses can be toxic in some patients:
| Factor | Effect | Mechanism |
|---|---|---|
| Chronic alcohol use | Increases toxicity | Induces CYP2E1 → more NAPQI; also depletes glutathione |
| Fasting / malnutrition | Increases toxicity | Reduces glutathione stores |
| Rifampicin, INH, Phenytoin, Carbamazepine, Barbiturates | Increases toxicity | CYP450 enzyme inducers → more NAPQI production |
| Chronic liver disease | Increases toxicity | Reduced hepatocyte mass + reduced glutathione |
| Children | Less susceptible | Higher sulphation capacity; different CYP450 profile |
Exam trap: Acute alcohol ingestion is actually protective (competes with CYP2E1, reducing NAPQI production). Chronic alcohol use is dangerous (induces CYP2E1, depletes glutathione). Students frequently get this reversed.
🏥 Section 3 — Clinical Stages of Paracetamol Overdose
This staging is one of the most tested clinical frameworks in pharmacology MCQs:
Stage 1 — The Latent Phase (0–24 hours)
- Patient feels relatively well — this is the deceptive window
- Mild nausea, vomiting, malaise, anorexia
- Liver enzymes (AST, ALT) are normal or only mildly elevated
- The danger: Patient and family may believe no serious harm has occurred
Stage 2 — Hepatic Injury Phase (24–72 hours)
- Right upper quadrant pain and hepatic tenderness develop
- Rising AST and ALT — can reach tens of thousands of IU/L
- Rising bilirubin, prolonged prothrombin time (PT/INR)
- Oliguria may develop (renal involvement)
- Peak hepatotoxicity begins to emerge
Stage 3 — Peak Hepatotoxicity (72–96 hours)
- Maximum liver damage — peak transaminase elevation
- Acute liver failure may develop: jaundice, coagulopathy, hepatic encephalopathy
- Acute kidney injury (hepatorenal syndrome or direct renal tubular toxicity by NAPQI)
- Metabolic acidosis, hypoglycaemia
- Mortality is highest in this phase
- Death or recovery is determined here
Stage 4 — Recovery Phase (4 days to 2 weeks)
- If the patient survives stage 3 without transplant, complete hepatic regeneration occurs
- Unlike many other causes of liver failure, paracetamol hepatotoxicity is fully reversible if the patient survives
- No chronic liver disease or fibrosis results from paracetamol overdose (unlike viral hepatitis or alcohol)
🧪 Section 4 — Diagnosis and the Rumack-Matthew Nomogram
Laboratory Investigations
- Serum paracetamol level — measured at 4 hours post-ingestion (earlier levels are unreliable due to ongoing absorption)
- AST/ALT — elevated; AST often rises faster and higher than ALT in paracetamol toxicity
- PT/INR — best marker of hepatic synthetic function; rising INR = worsening liver failure
- Serum creatinine — for renal involvement
- Arterial blood gas — lactic acidosis indicates poor prognosis
- Blood glucose — hypoglycaemia in severe liver failure
- Serum phosphate — rising phosphate in ALF indicates poor prognosis
The Rumack-Matthew Nomogram
This is a semi-logarithmic plot of serum paracetamol concentration against time after ingestion. It defines:
- Treatment line: Paracetamol level above this line at a given time → start N-acetylcysteine (NAC)
- Probable toxicity line: Even higher risk zone
- A 4-hour level of >150 mcg/mL (150 mg/L) is generally the threshold for treatment
Exam pearl: The nomogram is only valid for single acute ingestions — not for staggered overdoses or chronic ingestion. It requires an accurate time of ingestion. If time of ingestion is unknown, treat empirically.
💊 Section 5 — Treatment of Paracetamol Overdose
N-Acetylcysteine (NAC) — The Antidote
N-Acetylcysteine is the specific antidote for paracetamol toxicity. Understanding how it works is as important as knowing what it is.
Mechanisms of NAC:
- Glutathione precursor — NAC is deacetylated to cysteine, which is the rate-limiting precursor for glutathione synthesis → replenishes glutathione stores → allows NAPQI detoxification
- Direct NAPQI scavenger — NAC can directly bind and neutralise some NAPQI
- Antioxidant — reduces oxidative stress in damaged hepatocytes
- Improves hepatic microcirculation — vasodilatory effect that improves oxygen delivery
NAC is most effective when given within 8–10 hours of ingestion. However, it should still be given even after 24 hours in severe cases, as it continues to provide benefit even after hepatic injury is established.
NAC Administration Routes
| Route | Protocol | Notes |
|---|---|---|
| IV (preferred in severe cases) | 3-bag protocol over 21 hours (150 mg/kg loading → 50 mg/kg over 4h → 100 mg/kg over 16h) | Risk of anaphylactoid reaction — pretreat with antihistamine |
| Oral | 140 mg/kg loading dose, then 70 mg/kg every 4h × 17 doses | Nausea/vomiting limits compliance; IV preferred |
Other Treatment Measures
- Activated charcoal — if patient presents within 1–2 hours of ingestion (before absorption is complete); reduces paracetamol absorption by ~50%
- Supportive care — IV fluids, correction of hypoglycaemia, coagulopathy management
- Liver transplantation — for fulminant hepatic failure not responding to treatment
King’s College Criteria for Liver Transplantation in Paracetamol-Induced ALF
One of the most tested prognostic scores in hepatology:
Transplant is indicated if:
Arterial pH < 7.30 (after resuscitation)
OR all three of:
- PT > 100 seconds (INR > 6.5)
- Serum creatinine > 300 μmol/L (>3.4 mg/dL)
- Grade III or IV hepatic encephalopathy
Mnemonic for King’s College Criteria (Paracetamol): “pH below 7.3 = 1 criterion. Or the bad TRIAD: INR >6.5, Creatinine >300, Encephalopathy grade 3–4“
🏥 Section 6 — Other Hepatotoxic Drugs (For Comparison MCQs)
Examiners frequently test drug-induced liver injury by asking which drug causes which pattern of injury. Here is the high-yield comparison table:
| Drug | Type of Injury | Mechanism | Key Feature |
|---|---|---|---|
| Paracetamol | Centrilobular necrosis (Zone 3) | Dose-dependent, NAPQI, CYP2E1 | Most common cause of ALF |
| Valproate | Microvesicular steatosis, hepatitis | Mitochondrial toxicity, idiosyncratic | Children <2 years on polytherapy most at risk |
| Isoniazid (INH) | Hepatocellular necrosis | Idiosyncratic; toxic metabolite | Slow acetylators at higher risk; monitor LFTs |
| Rifampicin | Cholestatic hepatitis | Idiosyncratic | Competes with bilirubin uptake |
| Methotrexate | Hepatic fibrosis → cirrhosis | Direct toxicity; cumulative dose-dependent | Chronic use; liver biopsy to monitor |
| Tetracyclines | Microvesicular steatosis | Mitochondrial toxicity | IV tetracycline in pregnancy; now rare |
| Halothane | Fulminant hepatic necrosis | Immune-mediated (trifluoroacetyl hapten) | Repeated exposures; fever + eosinophilia |
| Amiodarone | Phospholipidosis, steatohepatitis | Mitochondrial toxicity | Resembles alcoholic hepatitis on biopsy |
| Chlorpromazine | Cholestatic jaundice | Idiosyncratic | Fever, jaundice, eosinophilia within 4 weeks |
| Oral contraceptives | Cholestasis, hepatic vein thrombosis (Budd-Chiari) | Oestrogen effect on bile secretion | Peliosis hepatis also associated |
| Azathioprine | Veno-occlusive disease, cholestasis | Metabolite toxicity | Post-transplant immunosuppression |
Two Patterns of Drug-Induced Liver Injury
1. Intrinsic (Predictable / Dose-dependent):
- Occurs in all individuals if dose is high enough
- Short latency period
- Reproducible in animal models
- Example: Paracetamol, carbon tetrachloride, methotrexate (chronic)
2. Idiosyncratic (Unpredictable):
- Occurs in susceptible individuals regardless of dose
- Variable latency (days to months)
- Not reproducible in animal models
- Two subtypes:
- Metabolic idiosyncratic: Abnormal drug metabolism (e.g., INH, valproate)
- Immune-mediated: Hapten formation triggers immune response (e.g., halothane, diclofenac)
🎯 High-Yield Exam Facts
These are the specific facts that appear repeatedly across NEET PG, USMLE, AIIMS and FMGE papers.
- 🔴 Paracetamol is the most common cause of acute liver failure — responsible for ~50% of ALF cases in Western countries; predominant cause of drug-induced ALF globally
- 🔴 Toxic metabolite = NAPQI — produced by CYP2E1; causes zone 3 (centrilobular) hepatic necrosis
- 🔴 Antidote = N-Acetylcysteine (NAC) — works by replenishing glutathione; most effective within 8–10 hours
- 🔴 Toxic dose in adults = >7.5–10 g (approximately 15–20 standard 500mg tablets); lower in high-risk groups
- 🔴 King’s College Criteria — pH <7.30 alone, OR the triad of INR >6.5 + creatinine >300 + grade III/IV encephalopathy → indicates need for liver transplant
- 🟠 Chronic alcohol use increases paracetamol toxicity (CYP2E1 induction + glutathione depletion) — acute alcohol is relatively protective
- 🟠 CYP450 inducers (rifampicin, phenytoin, carbamazepine, INH, barbiturates) increase paracetamol toxicity by increasing NAPQI production
- 🟠 Zone 3 (centrilobular) necrosis is the histological pattern of paracetamol toxicity — highest CYP2E1 concentration is in zone 3
- 🟠 Stage 1 of paracetamol overdose is deceptively mild — the dangerous delay in diagnosis occurs here
- 🟠 Valproate hepatotoxicity — microvesicular steatosis; mitochondrial mechanism; most dangerous in children <2 years on polytherapy with enzyme inducers
- 🟡 Halothane hepatitis — fulminant necrosis; immune-mediated via trifluoroacetyl hapten; occurs after repeated exposure; associated with fever + eosinophilia
- 🟡 Tetracyclines (especially IV) cause microvesicular steatosis — mechanism is mitochondrial toxicity; historically important in pregnant women; now rare
- 🟡 Methotrexate causes fibrosis → cirrhosis with chronic use — cumulative dose-dependent; liver biopsy recommended after 1.5g cumulative dose
- 🟡 Activated charcoal is only useful within 1–2 hours of paracetamol ingestion — beyond this, absorption is complete and charcoal has no benefit
🧠 Mnemonics & Memory Tricks
Mnemonic 1: “NAPQI = Naughty And Protein-binding Quinone Imine” Stands for: Reminds you that NAPQI is the naughty reactive metabolite of paracetamol that covalently binds proteins → causing hepatocyte necrosis Use it for: Connecting paracetamol → CYP2E1 → NAPQI → protein binding → Zone 3 necrosis in one mental chain
Mnemonic 2: “GASSED” — Factors increasing paracetamol toxicity Glutathione depletion (fasting, malnutrition) Alcohol (chronic use) Slow acetylators (for INH comparison — but here, enzyme inducers matter) Starvation Enzyme inducers (rifampicin, phenytoin, carbamazepine, barbiturates) Disease (pre-existing liver disease) Use it for: Listing high-risk groups for paracetamol hepatotoxicity in clinical scenario questions
Mnemonic 3: “NAC Gives Glutathione” N-Acetylcysteine → provides Cysteine → rate-limiting precursor for Glutathione synthesis → quenches NAPQI Use it for: Explaining the mechanism of the antidote in one step — simple and accurate
Mnemonic 4: King’s College Criteria — “One pH or a BAD TRIAD“
- One criterion alone: pH < 7.3
- BAD TRIAD: Big INR (>6.5) + Acute kidney (Creatinine >300) + Dense encephalopathy (grade 3–4) Use it for: Instantly recalling transplant criteria in clinical scenario questions
⚠️ Common Mistakes Students Make
❌ Mistake: “Paracetamol is safe in all doses — it’s just a mild painkiller” ✅ Reality: Paracetamol is the most common cause of acute liver failure in many countries precisely because of its perceived safety. The therapeutic window is narrow in high-risk groups (alcohol users, malnourished patients, those on enzyme inducers), and even slightly supratherapeutic doses can cause severe hepatotoxicity. 📝 Exam trap: A clinical scenario describes a “therapeutic misadventure” — patient takes slightly more than the recommended dose over several days due to pain → develops liver failure. This is staggered overdose and is just as dangerous as acute overdose.
❌ Mistake: “Acute alcohol use worsens paracetamol toxicity” ✅ Reality: Acute alcohol competes with paracetamol for CYP2E1, actually reducing NAPQI formation acutely. It is chronic alcohol use that induces CYP2E1 and depletes glutathione, dramatically increasing toxicity. This counterintuitive distinction is a favourite exam trap. 📝 Exam trap: “A patient who drank alcohol tonight took a paracetamol overdose — is he at higher or lower acute risk than a sober patient?” — Lower acute risk due to CYP competition. But his chronic alcohol use history is the real danger factor.
❌ Mistake: “N-Acetylcysteine is only useful in the first few hours” ✅ Reality: While NAC is most effective within 8–10 hours, it should be given even at 24–36 hours or beyond in patients presenting late, as it still provides benefit by improving hepatic perfusion, providing antioxidant support, and aiding recovery of damaged hepatocytes. 📝 Exam trap: “A patient presents 20 hours after paracetamol overdose. Should NAC be given?” — Yes, absolutely.
❌ Mistake: “Valproate hepatotoxicity has the same mechanism as paracetamol” ✅ Reality: Valproate causes liver injury through mitochondrial toxicity → microvesicular steatosis — a completely different mechanism from paracetamol’s NAPQI-mediated Zone 3 necrosis. Valproate toxicity is largely idiosyncratic (not dose-dependent in the way paracetamol is) and is most dangerous in young children on polytherapy. 📝 Exam trap: MCQs ask “which drug causes microvesicular steatosis?” — answer is valproate or tetracycline, not paracetamol (which causes coagulative necrosis).
❌ Mistake: “Warfarin causes acute liver failure” ✅ Reality: Warfarin does not cause significant hepatotoxicity or acute liver failure. It prolongs PT/INR by inhibiting vitamin K-dependent clotting factors (II, VII, IX, X) — not by damaging hepatocytes. In ALF questions, warfarin is a distractor option included because students associate it with coagulopathy. 📝 Exam trap: The MCQ in question listed warfarin as an option — it was there to catch students who think “coagulopathy in liver failure = warfarin involvement.” The coagulopathy in ALF is from hepatocyte destruction, not anticoagulants.
🔗 How This Topic Connects to Others
Mastering paracetamol hepatotoxicity opens direct connections to multiple high-yield topic areas:
- CYP450 pharmacology — Understanding enzyme induction (rifampicin, phenytoin, carbamazepine) and how it increases NAPQI production is core CYP450 pharmacology tested across dozens of drug interaction questions
- Glutathione and oxidative stress — GSH depletion and reactive oxygen species connect to toxicology, biochemistry, and the mechanism of several other drugs (cyclophosphamide, bleomycin)
- Hepatic zones (Rappaport acinus) — Zone 1 injury (periportal) in phosphorus poisoning; Zone 3 injury (centrilobular) in paracetamol and CCl4; zone-specific pathology is repeatedly tested
- Acute liver failure management — Hepatic encephalopathy staging, lactulose, rifaximin, liver transplant criteria — all build on the foundation of ALF pathophysiology
- Antidotes in pharmacology — NAC for paracetamol fits into the larger antidote framework: naloxone for opioids, flumazenil for benzodiazepines, atropine for organophosphates, deferoxamine for iron
- Reye’s syndrome — Aspirin + viral illness in children causes mitochondrial injury + microvesicular steatosis — mechanistically similar to valproate toxicity and important for paediatric pharmacology
❓ The MCQ That Started This — Fully Explained
Question: Most commonly implicated drug for acute liver failure is:
- A. Paracetamol
- B. Valproate
- C. Warfarin
- D. Tetracyclines
✅ Correct Answer: A. Paracetamol
Why correct: Paracetamol (acetaminophen) is the most common cause of acute liver failure both globally and in Western countries, accounting for approximately 50% of all ALF cases. Its toxicity is predictable, dose-dependent, and mediated by NAPQI — the reactive metabolite produced by CYP2E1 when glucuronidation and sulphation pathways are saturated in overdose. Massive hepatocyte necrosis (zone 3) follows glutathione depletion.
Why B is wrong: Valproate can cause serious hepatotoxicity — particularly microvesicular steatosis and fulminant hepatic failure in young children on polytherapy — but it is an idiosyncratic reaction that is far less common than paracetamol toxicity. Valproate is not the most common cause of drug-induced ALF overall.
Why C is wrong: Warfarin does not cause hepatotoxicity or acute liver failure. It is an anticoagulant that inhibits vitamin K-dependent clotting factor synthesis — producing coagulopathy without hepatocyte damage. The presence of coagulopathy in ALF is due to impaired hepatic synthesis, not warfarin. Warfarin is a deliberate distractor in this MCQ.
Why D is wrong: Tetracyclines (particularly intravenous tetracycline in high doses) can cause microvesicular fatty change (steatosis) of the liver through mitochondrial toxicity. Historically this was seen in pregnant women receiving IV tetracycline. However, this is an uncommon form of drug-induced liver disease and tetracycline is not the most commonly implicated drug in ALF.
📝 Test Your Understanding — 5 Practice MCQs
Q1. The toxic metabolite of paracetamol responsible for hepatic necrosis is:
- A. Paracetamol glucuronide
- B. N-Acetyl-p-Benzoquinone Imine (NAPQI)
- C. Paracetamol sulphate
- D. Acetylsalicylic acid
✅ **B. N-Acetyl-p-Benzoquinone Imine (NAPQI)** — NAPQI is produced by CYP2E1 oxidation of paracetamol. At therapeutic doses, it is immediately detoxified by glutathione. In overdose, glutathione stores are depleted and free NAPQI covalently binds hepatocyte proteins, causing zone 3 (centrilobular) necrosis. Glucuronide and sulphate conjugates are non-toxic excretory products.
Q2. A 45-year-old chronic alcoholic takes 6 grams of paracetamol over 24 hours for back pain — a dose slightly above the recommended maximum. He develops acute liver failure. Which of the following best explains his vulnerability?
- A. Alcohol inhibits glucuronidation, reducing paracetamol clearance
- B. Chronic alcohol induces CYP2E1 and depletes glutathione stores
- C. Alcohol directly inhibits N-acetylcysteine metabolism
- D. Acute alcohol intoxication increases CYP2E1 activity
✅ **B. Chronic alcohol induces CYP2E1 and depletes glutathione stores** — Chronic alcohol consumption upregulates CYP2E1 (the enzyme that converts paracetamol to NAPQI) and simultaneously depletes hepatic glutathione (the defence against NAPQI). Together, these effects make even slightly supratherapeutic doses of paracetamol dangerous in chronic alcohol users. Note that **acute** alcohol ingestion is actually relatively protective, as it competes with paracetamol for CYP2E1.
Q3. A 17-year-old girl is brought to the emergency department 6 hours after ingesting 25 paracetamol tablets (500 mg each). She appears well and denies any symptoms. Serum paracetamol level is above the treatment line on the Rumack-Matthew nomogram. What is the most appropriate immediate management?
- A. Reassure and discharge — she appears well
- B. Administer activated charcoal only
- C. Start IV N-acetylcysteine immediately
- D. Wait for ALT to rise before treating
✅ **C. Start IV N-acetylcysteine immediately** — The Rumack-Matthew nomogram indicates significant risk of hepatotoxicity based on the serum paracetamol level at 6 hours. The fact that she appears well is characteristic of Stage 1 (latent phase) — the deceptive symptom-free window. NAC must be started immediately; waiting for symptoms or rising ALT means waiting until irreversible hepatic damage has occurred. Activated charcoal alone at 6 hours is insufficient (absorption largely complete). NAC is most effective within 8–10 hours.
Q4. Which of the following histological patterns is characteristically seen in paracetamol-induced liver injury?
- A. Zone 1 (periportal) necrosis
- B. Zone 2 (midzonal) necrosis
- C. Zone 3 (centrilobular) necrosis
- D. Microvesicular steatosis throughout all zones
✅ **C. Zone 3 (centrilobular) necrosis** — CYP2E1, the enzyme responsible for converting paracetamol to NAPQI, is most concentrated in zone 3 (perivenular/centrilobular zone) of the hepatic acinus. This zone is also the most oxygen-deficient, making it least able to recover from metabolic insult. Zone 1 necrosis is seen in phosphorus poisoning and eclampsia. Zone 2 necrosis is seen in yellow fever. Microvesicular steatosis is seen in valproate and tetracycline toxicity.
Q5. A 52-year-old man is admitted with paracetamol-induced acute liver failure. His arterial pH is 7.25 despite resuscitation. His INR is 7.2, serum creatinine is 340 μmol/L, and he has Grade IV hepatic encephalopathy. What is the most appropriate next step in management?
- A. Increase the dose of N-acetylcysteine and continue conservative management
- B. Start haemodialysis only
- C. Refer urgently for liver transplantation
- D. Administer fresh frozen plasma to correct coagulopathy and reassess
✅ **C. Refer urgently for liver transplantation** — This patient meets King’s College Criteria for liver transplantation on two independent grounds: (1) arterial pH <7.30 alone is sufficient, AND (2) he has the full triad of INR >6.5 + creatinine >300 μmol/L + Grade III/IV encephalopathy. Both criteria independently indicate that the prognosis without transplantation is very poor. Correcting the INR with FFP is not therapeutic (just masks the coagulopathy) and delays transplant listing. NAC should continue alongside transplant workup, but conservative management alone is insufficient at this stage.
📚 References & Further Reading
- Katzung’s Basic & Clinical Pharmacology — Chapter on Hepatotoxic Drugs; Chapter on NSAIDs and Paracetamol
- Harrison’s Principles of Internal Medicine — Chapter on Toxic and Drug-Induced Hepatitis; Chapter on Acute Liver Failure
- Robbins & Cotran Pathologic Basis of Disease — Chapter on Liver Pathology: Drug-Induced and Toxic Liver Disease; Hepatic Zones of Injury
- Goodman & Gilman’s The Pharmacological Basis of Therapeutics — Chapter on Drug Metabolism (CYP450) and Paracetamol Toxicology
- Bailey & Love’s Short Practice of Surgery — Chapter on Liver Failure and Transplantation Criteria (King’s College Criteria)
🚀 Ready to Master Pharmacology & Medicine?
You’ve just covered one of the most high-yield intersections of Pharmacology and Internal Medicine. Paracetamol hepatotoxicity alone connects CYP450, glutathione biochemistry, clinical staging, antidote pharmacology, and transplant criteria — all in one question cluster.
medicalmcq.in has 500+ free Pharmacology MCQs — each with detailed explanations just like this article.
When you’re ready to simulate real exam pressure, our Mock Test Series gives you timed, subject-wise and full-length tests with performance analytics — so you know exactly where to focus next.
